Azurity Pharma Recalls Narcolepsy Drug Zenzedi 30 Mg
Azurity Pharmaceuticals, Inc. is recalling one lot of Zenzedi CII (dextroamphetamine sulfate tablets, USP) 30 mg to the consumer level, according to the U.S. Food and Drug Administration.
Source: rttnews.com